Risk of demyelinating events associated with TNF-inhibitors compared with conventional synthetic disease modifying anti-rheumatic drugs in rheumatoid arthritis: Results from the French National Health Data System

Joint Bone Spine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles